Skip to content

Study of Patient Navigation to Reduce Social Inequalities

The Patient Navigator to Reduce Social Inequalities. A French Interventional Trial in Public Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01555450
Acronym
PRADO
Enrollment
28929
Registered
2012-03-15
Start date
2011-03-31
Completion date
2013-11-30
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer Screening

Keywords

Colorectal cancer screening, Social inequalities, Patient Navigator

Brief summary

Variations in participation to the colorectal cancer screening seems to reveal social and geographical inequalities. Our study will investigate whether patient navigation could increase the participation to the colorectal cancer screening and in the same time, reduce the social inequalities.

Interventions

OTHERPatient Navigation

Insured people receive firstly a letter to inform them that a patient navigator is available to navigate them during the colorectal screening steps. A free telephone number and the navigator schedule is given. After a minimum of one week the patient navigator begins the telephone outreach.

Sponsors

National Cancer Institute, France
CollaboratorOTHER_GOV
Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
50 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

* Insured people invited to the national french colorectal screening program are from 50 to 74 years old. * We select people who never do the screening test or are not compliant with it * Among these people we select those living in the randomized geographical areas.

Exclusion criteria

* people who have already done the screening test at the two previous campaigns. * people who have done a colonoscopy in the previous five years or people with a family history with colorectal cancer and people who are following outside of the screening program. * people with other severe disease or in incapacity to realize the screening test * people who have another

Design outcomes

Primary

MeasureTime frameDescription
Completion of colorectal cancer screening2 years
Reduction of social inequalities2 yearsThe participation rate to the colorectal cancer screening will be compared between privileged and deprived geographical areas for which the socio-economic status is measured with the Townsend index.

Secondary

MeasureTime frameDescription
Estimation of Cost effectiveness2 yearsWe will assess the mean cost to navigate one person and compared it to a non navigate person. We will measure the cost effectiveness of the intervention in order to have the cost of the arising of 1% of the participation rate.
Evaluation of psychological mechanisms2 yearsEvaluation of cognitive, behavioural, emotional mechanisms influencing the colorectal screening participation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026